# Phase 3 Weekly Review

Current status: Phase 3 is active, not complete.

## Real Users

- Real developers onboarded: 0
- Target: 10

## Diagnosis Accuracy

- Confirmed real-world diagnoses: 0
- Correct real-world diagnoses: 0
- Accuracy estimate: unknown
- Target: around 70%+

## Most Common Failure Types

- Unknown until real traces arrive.

## Most Useful Fixes

- Unknown until users try suggested fixes.

## Biggest Trust Failures

- Not observed yet.
- Risk: users may distrust overconfident diagnoses if traces are sparse or messy.

## What Users Actually Care About

- Unknown until beta calls.
- Hypothesis: exact failed step, concrete fix, and whether the explanation matches their trace.

## UI vs Accuracy

- No evidence users need UI yet.
- Current priority remains better diagnosis accuracy from real traces.

## Exit Criteria

Do not move to Phase 4 until all are true:

- 10+ real developers used AgentLens.
- Around 70%+ confirmed diagnosis usefulness.
- At least 3 users explicitly said they would pay.
- Onboarding friction is manageable.
- Users trust diagnoses.
- Real-world traces validate the RCA engine.

## Next Actions

- DM 10 target developers using `launch/dm_template.md`.
- Run one beta user through `docs/beta_test_checklist.md`.
- Save anonymized traces in `real_world_cases/`.
- Update `feedback/users.csv` after every interaction.
- Add unknown patterns to `docs/new_failure_patterns.md` instead of expanding categories immediately.
